Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2017-05-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于更换保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the replacement of the sponsor representative for the company's IPO continuous supervision. It mentions the change of the sponsor representative due to the previous representative's departure and introduces the new representatives. There is no financial data, report, or detailed financial analysis included. The document is a regulatory announcement about management of the IPO sponsorship and supervision, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement rather than a report itself.
2017-05-26 Chinese
2016年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the company's 2016 annual dividend distribution plan, including details on dividend amounts, payment dates, shareholder meeting approvals, and related procedural information. It specifies the dividend per share, record date, ex-dividend date, and payment date. The document is relatively short (2161 characters) and focuses solely on the dividend distribution details without containing full financial statements or comprehensive financial performance data. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2017-05-23 Chinese
2016年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the Annual General Meeting (AGM) of the company 葵花药业集团股份有限公司 for the year 2016. It details the voting results on various proposals including the 2016 annual reports, financial statements, profit distribution plans, and other corporate matters. The document includes specifics about the meeting date, voting methods, attendance, and legal opinions confirming the validity of the meeting and voting process. It does not contain the full annual report or financial statements themselves but rather the official announcement of the voting results from the AGM. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4339 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2017-05-19 Chinese
2016年度股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the 2016 Annual General Meeting (AGM) of a company. It details the procedures for convening and holding the AGM, the qualifications of attendees, the voting procedures, and the results of the votes on various agenda items. The document includes legal verification that the AGM was conducted in compliance with relevant laws and company regulations. It does not contain financial statements or detailed financial performance data, but rather focuses on the legality and validity of the AGM process and voting outcomes. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the results of shareholder votes at the AGM.
2017-05-19 Chinese
关于使用闲置募集资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of idle raised funds to purchase financial products. It details the investment product, risk disclosures, approvals by the board, independent directors, supervisory board, and the sponsor institution. It is a formal disclosure about financing activities related to the use of capital raised by the company, specifically the purchase of wealth management products with idle raised funds. There are no financial statements or comprehensive financial performance data presented, nor is it a report or transcript. The document is not a report publication announcement since it contains substantive information about the transaction and approvals. This fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and capital usage activities.
2017-05-03 Chinese
2016年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2016 年年度报告全文" which translates to "2016 Annual Report Full Text" for 葵花药业集团股份有限公司 (Sunflower Pharmaceutical Group Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, business analysis, governance, and financial statements. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes comprehensive financial figures, management discussion and analysis, and other detailed disclosures consistent with an official yearly report. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2016
2017-04-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.